Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-04-25
2006-04-25
Kim, Vickie (Department: 1614)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C514S291000, C514S312000, C514S772000, C424S401000
Reexamination Certificate
active
07033604
ABSTRACT:
The present invention provides a composition for topical administration comprising an interleukin 2 inhibitor and an antimicrobial agent as active ingredients thereof, wherein said interleukin 2 inhibitor contains a tricyclo compound as shown by the general formula (I) or pharmaceutically acceptable salt thereof. The present invention further provides a method for treating inflammations and/or infections comprising topical administration of an effective amount of an interleukin 2 inhibitor and an antimicrobial agent to a subject in need of the treatment of inflammations and/or infections.
REFERENCES:
patent: 5348966 (1994-09-01), Starzl et al.
patent: 5385907 (1995-01-01), Asakura et al.
patent: 5474764 (1995-12-01), Patel et al.
patent: 5514686 (1996-05-01), Mochizuki et al.
patent: 5880101 (1999-03-01), Stankov
patent: 5885601 (1999-03-01), Sokal
patent: 5912255 (1999-06-01), Bussell
patent: 5939427 (1999-08-01), Kagayama et al.
patent: 6017554 (2000-01-01), Ratcliff
patent: 6087358 (2000-07-01), Baker et al.
patent: 6140355 (2000-10-01), Egidio et al.
patent: 6174859 (2001-01-01), Lezdey et al.
patent: 6191143 (2001-02-01), Watts et al.
patent: 6248776 (2001-06-01), Harris
patent: 6312715 (2001-11-01), Cantor et al.
patent: 6359016 (2002-03-01), Singh et al.
patent: 6475518 (2002-11-01), Baumgart et al.
patent: 2003/0044452 (2003-03-01), Ueno
patent: 2003/0114416 (2003-06-01), Pulaski et al.
patent: 2004/0019054 (2004-01-01), Roark
patent: WO 00/50007 (2000-08-01), None
patent: WO00/66122 (2000-11-01), None
patent: WO 02/085359 (2002-10-01), None
patent: WO 00/66122 (2002-11-01), None
U.S. Copending Appl. No. 10/495,425 filed May 21, 2004 and U.S. Appl. No. 10/523,842 filed Feb. 8, 2005.
Interactions Between Tacrolimus and Antimicrobial Agents; David L. Paterson and Nina Singh; Dec. 1997; pp. 1430-1440.
Effects of Twenty-Three Drugs on The Metabolism of FK506 by Human Liver Microsomes; Kazuhide Iwasaki, Hiroji Matsuda, Kazuko Nagase, Toshifumi Shiraga, Yoji Tokuma, Kazuharu Uchida; Nov. 1993; pp. 209-216.
Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation; Roman A. McLellan, Robert K. Drobitch, D. Heather McLellan, Philip D. Acott, John F.S. Crocker, Kenneth W. Renton; 1995; pp. 322-327.
Pharmacokinetic Drug Interactions with Antimicrobial Agents; J. Gregory Gillum, Debra S. Israel, Ron E. Polk; 1993; pp. 450-482.
U.S. Appl. No. 10/495,425, filed May 21, 2004, Ueno.
U.S. Appl. No. 10/523,842, filed Feb. 8, 2005, Ueno.
Kim Vickie
Sucampo AG
LandOfFree
Composition for topical administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for topical administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for topical administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597569